| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | MAGEA2 SETD1A NCOA6 TCF12 HDAC6 ZNF618 PHF12 ARID1A ATF2 TFDP1 IKZF4 PTPRN BAZ2A KLF5 MYOCD PAX3 DOT1L SPEN MNDA TP73 | 2.65e-06 | 753 | 160 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | IRF2BP2 BCL9L NCOA6 SYNPO2 TCF20 PHF12 KSR2 MAML1 AMBRA1 NLRP1 BCL9 ARID1A SH2B1 ZIC3 ARID1B BAZ2A SETD5 TONSL MYOCD YY1AP1 IRS2 DOT1L SPEN GAB1 | 1.79e-05 | 1160 | 160 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | IRF2BP2 BCL9L NCOA6 SYNPO2 TCF20 PHF12 KSR2 MAML1 AMBRA1 NLRP1 BCL9 ARID1A SH2B1 ZIC3 ARID1B BAZ2A SETD5 TONSL OTUD4 DLG1 MYOCD YY1AP1 IRS2 DOT1L SPEN GAB1 | 2.86e-05 | 1356 | 160 | 26 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | IRF2BP2 BCL9L NCOA6 TCF20 PHF12 MAML1 BCL9 ARID1A ZIC3 ARID1B SETD5 MYOCD YY1AP1 DOT1L SPEN | 4.81e-05 | 562 | 160 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.71e-04 | 303 | 160 | 10 | GO:0003713 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX15 HIVEP1 TCF12 HDAC6 ZNF280D ZKSCAN8 SIX4 RFX2 ATF2 TFDP1 E2F8 IKZF4 ZIC3 ELL2 SLC2A4RG ZFHX4 KLF5 GLI3 PAX3 SNAPC4 TET3 NPAS4 TP73 | 2.05e-04 | 1271 | 160 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | protein domain specific binding | CACNA1D NCOA6 HIVEP1 TCF12 NCKIPSD NUMA1 NLRP1 DNAJC6 ATF2 TFDP1 IKZF4 TGFBR3 ARHGAP6 ATXN1 ZBTB21 DLG1 IRS2 PAX3 | 2.34e-04 | 875 | 160 | 18 | GO:0019904 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | MAGEA2 SETD1A NCOA6 TCF12 ARID1A ATF2 TFDP1 IKZF4 BAZ2A KLF5 MYOCD DOT1L SPEN TP73 | 2.54e-04 | 582 | 160 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | actinin binding | 3.84e-04 | 43 | 160 | 4 | GO:0042805 | |
| GeneOntologyMolecularFunction | POZ domain binding | 6.28e-04 | 5 | 160 | 2 | GO:0031208 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 7.95e-04 | 23 | 160 | 3 | GO:0071837 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX15 HIVEP1 TCF12 HDAC6 ZNF280D ZKSCAN8 SIX4 RFX2 ATF2 E2F8 IKZF4 ZIC3 SLC2A4RG ZFHX4 KLF5 GLI3 PAX3 SNAPC4 TET3 NPAS4 TP73 | 9.72e-04 | 1244 | 160 | 21 | GO:0000978 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | BCL9L NCOA6 HIVEP1 TCF12 TCF20 GPER1 MAML1 EYA1 SIX4 BCL9 RFX2 ATF2 TFDP1 E2F8 IKZF4 ZIC3 JAK3 ELL2 PTPRN ATXN1 KLF5 GLI3 MYOCD PAX3 DOT1L TET3 AGRN NPAS4 TP73 PYGO1 | 3.25e-07 | 1390 | 161 | 30 | GO:0045944 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ICOSLG EP400 RBBP6 BCL7B USP43 EYA1 ARID1A POLA2 INO80D SH2B1 TFDP1 E2F8 TFRC PARP4 HROB ARID1B PSME4 TONSL OTUD4 FMN2 ANKRD17 DOT1L TP73 RNF212B | 3.58e-06 | 1081 | 161 | 24 | GO:0006259 |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.16e-05 | 65 | 161 | 6 | GO:0045815 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.51e-05 | 68 | 161 | 6 | GO:0141137 | |
| GeneOntologyBiologicalProcess | muscle tissue development | BCL9L HDAC6 MAML1 EYA1 SIX4 BCL9 ARID1A PDLIM5 ZIC3 TGFBR3 KLF5 DLG1 MYOCD PAX3 TP73 | 3.30e-05 | 558 | 161 | 15 | GO:0060537 |
| GeneOntologyBiologicalProcess | DNA damage response | SETD1A NCOA6 EP400 RBBP6 BCL7B USP43 EYA1 ARID1A ATF2 INO80D PARP4 HROB ARID1B PSME4 TONSL OTUD4 FMN2 DOT1L MNDA TP73 | 6.02e-05 | 959 | 161 | 20 | GO:0006974 |
| GeneOntologyBiologicalProcess | chordate embryonic development | TBX15 TANC2 NCOA6 DSC3 RBBP6 AMBRA1 EYA1 SIX4 ARID1A ATF2 E2F8 ZIC3 TGFBR3 GLI3 KIAA1217 UNK DLG1 PAX3 GAB1 | 8.67e-05 | 906 | 161 | 19 | GO:0043009 |
| GeneOntologyBiologicalProcess | skeletal muscle cell differentiation | 1.07e-04 | 96 | 161 | 6 | GO:0035914 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TBX15 TANC2 NCOA6 DSC3 RBBP6 AMBRA1 EYA1 SIX4 ARID1A ATF2 E2F8 ZIC3 TGFBR3 GLI3 KIAA1217 UNK DLG1 PAX3 GAB1 | 1.20e-04 | 929 | 161 | 19 | GO:0009792 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 1.33e-04 | 143 | 161 | 7 | GO:0045739 | |
| GeneOntologyBiologicalProcess | embryonic organ development | TBX15 NCOA6 RBBP6 EYA1 SIX4 ARID1A E2F8 ZIC3 LRIG1 GLI3 DLG1 STRC GAB1 STRCP1 | 1.34e-04 | 561 | 161 | 14 | GO:0048568 |
| GeneOntologyBiologicalProcess | muscle structure development | MYBPH BCL9L TCF12 HDAC6 GPER1 MYOM3 MAML1 EVC SIX4 BCL9 ARID1A PDLIM5 TGFBR3 ARID1B KLF5 ANKRD17 MYOCD PAX3 | 1.34e-04 | 858 | 161 | 18 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | EP400 RBBP6 BCL7B EYA1 ARID1A INO80D SH2B1 TFDP1 E2F8 TFRC PARP4 ARID1B FMN2 ANKRD17 | 1.41e-04 | 564 | 161 | 14 | GO:0051052 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 1.68e-04 | 198 | 161 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | DNA repair | EP400 BCL7B USP43 EYA1 ARID1A INO80D PARP4 HROB ARID1B PSME4 TONSL OTUD4 FMN2 DOT1L TP73 | 1.75e-04 | 648 | 161 | 15 | GO:0006281 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYBPH HDAC6 MYOM3 MAML1 SIX4 BCL9 ARID1A PDLIM5 KLF5 MYOCD PAX3 | 2.60e-04 | 391 | 161 | 11 | GO:0051146 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYBPH HDAC6 GPER1 MYOM3 MAML1 SIX4 BCL9 ARID1A PDLIM5 KLF5 ANKRD17 MYOCD PAX3 | 2.81e-04 | 531 | 161 | 13 | GO:0042692 |
| GeneOntologyCellularComponent | transcription regulator complex | TBX15 BCL9L NCOA6 TCF12 PHF12 SIX4 BCL9 ATF2 TFDP1 E2F8 KLF5 GLI3 MYOCD PAX3 SNAPC4 SPEN NPAS4 | 3.41e-06 | 596 | 160 | 17 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear body | MAGEA2 SETD1A HIVEP1 TCF12 TCF20 EP400 RBBP6 MAML1 COP1 EYA1 CMYA5 IKZF4 SLC2A4RG PSME4 BAZ2A GLI3 TONSL YY1AP1 PKN2 N4BP1 MNDA | 5.69e-06 | 903 | 160 | 21 | GO:0016604 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TBX15 BCL9L SETD1A NCOA6 TCF12 HDAC6 EP400 PHF12 BCL7B NCKIPSD POM121L2 BCL9 ARID1A POLA2 ATF2 INO80D TFDP1 E2F8 ARID1B ELL2 BAZ2A SETD5 MCM3AP TONSL MYOCD YY1AP1 AFF4 | 5.77e-06 | 1377 | 160 | 27 | GO:0140513 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.09e-06 | 96 | 160 | 7 | GO:0070603 | |
| GeneOntologyCellularComponent | chromatin | TBX15 SETD1A TCF12 EP400 ZNF618 PHF12 BCL7B SIX4 ARID1A RFX2 ATF2 INO80D TFDP1 E2F8 ARID1B ZFHX4 BAZ2A SETD5 KLF5 TONSL ANKRD17 MYOCD YY1AP1 PAX3 NPAS4 AFF4 TP73 | 2.11e-05 | 1480 | 160 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | ATPase complex | 6.17e-05 | 129 | 160 | 7 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear speck | SETD1A TCF12 EP400 RBBP6 MAML1 COP1 CMYA5 SLC2A4RG PSME4 BAZ2A GLI3 MNDA | 1.25e-04 | 431 | 160 | 12 | GO:0016607 |
| GeneOntologyCellularComponent | nuclear chromosome | 7.77e-04 | 254 | 160 | 8 | GO:0000228 | |
| MousePheno | pericardial effusion | 8.92e-06 | 111 | 130 | 8 | MP:0005312 | |
| MousePheno | abnormal forelimb stylopod morphology | 2.33e-05 | 92 | 130 | 7 | MP:0003854 | |
| MousePheno | abnormal humerus morphology | 2.33e-05 | 92 | 130 | 7 | MP:0005296 | |
| MousePheno | abnormal pericardium morphology | 4.72e-05 | 225 | 130 | 10 | MP:0000288 | |
| MousePheno | prenatal growth retardation | NCOA6 TCF20 RBBP6 RTTN MAML1 GNPNAT1 INO80D TFDP1 ZIC3 TFRC TGFBR3 SETD5 GLI3 TONSL ANKRD17 DLG1 RPRD2 MYOCD DOT1L AFF4 GAB1 | 4.94e-05 | 869 | 130 | 21 | MP:0010865 |
| MousePheno | short humerus | 8.00e-05 | 48 | 130 | 5 | MP:0004351 | |
| MousePheno | abnormal mammary line morphology | 8.58e-05 | 2 | 130 | 2 | MP:0013720 | |
| MousePheno | effusion | 8.61e-05 | 152 | 130 | 8 | MP:0021205 | |
| MousePheno | abnormal embryo development | BCL9L SETD1A NCOA6 EP400 RBBP6 RTTN GNPNAT1 ARID1A PGAP6 INO80D TFDP1 ZIC3 TFRC TYR TGFBR3 SETD5 KLF5 GLI3 TONSL ANKRD17 RPRD2 MYOCD PKN2 PAX3 DOT1L AFF4 TP73 | 1.28e-04 | 1370 | 130 | 27 | MP:0001672 |
| MousePheno | abnormal cartilaginous joint morphology | 1.38e-04 | 85 | 130 | 6 | MP:0030875 | |
| MousePheno | abnormal laryngeal cartilage morphology | 1.42e-04 | 29 | 130 | 4 | MP:0002256 | |
| Domain | BCL9 | 6.93e-05 | 2 | 156 | 2 | PF11502 | |
| Domain | BAF250/Osa | 6.93e-05 | 2 | 156 | 2 | IPR021906 | |
| Domain | Bcl-9 | 6.93e-05 | 2 | 156 | 2 | IPR015668 | |
| Domain | BCL9_beta-catenin-bd_dom | 6.93e-05 | 2 | 156 | 2 | IPR024670 | |
| Domain | BAF250_C | 6.93e-05 | 2 | 156 | 2 | IPR033388 | |
| Domain | BAF250_C | 6.93e-05 | 2 | 156 | 2 | PF12031 | |
| Pubmed | IRF2BP2 BCL9L SETD1A NCOA6 HIVEP1 TCF12 TCF20 EP400 RBBP6 PHF12 BCL7B NUMA1 MAML1 COP1 PROSER1 PPP6R1 SIX4 BCL9 ARID1A INO80D TFDP1 ZIC3 TFRC ARID1B ZFHX4 ATXN1 KLF5 GLI3 ZBTB21 OTUD4 ANKRD17 UNK RPRD2 YY1AP1 N4BP1 DOT1L SPEN PYGO1 | 1.83e-18 | 1429 | 163 | 38 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L SETD1A NCOA6 HIVEP1 TCF20 EP400 PHF12 BCL7B MAML1 PROSER1 SIX4 BCL9 ARID1A TFDP1 TFRC ARID1B ZFHX4 ATXN1 MCM3AP SPEN RAI1 | 2.65e-17 | 351 | 163 | 21 | 38297188 |
| Pubmed | IRF2BP2 BCL9L NCOA6 HIVEP1 TCF20 EP400 PHF12 BCL7B MAML1 BCL9 ARID1A ATF2 ARID1B ATXN1 KLF5 ZBTB21 RPRD2 AFF4 RAI1 | 4.10e-17 | 268 | 163 | 19 | 33640491 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | IRF2BP2 NCOA6 HIVEP1 HDAC6 TCF20 EP400 RBBP6 PHF12 SAMD4B NUMA1 BCL9 POLA2 ATF2 BAZ2A ZBTB21 OTUD4 ANKRD17 UNK DLG1 YY1AP1 PKN2 IRS2 SNAPC4 SPEN | 2.81e-13 | 774 | 163 | 24 | 15302935 |
| Pubmed | TANC2 TCF12 HDAC6 EP400 RBBP6 ZNF618 PHF12 BCL7B AMBRA1 PPP6R1 ARID1A INO80D TFDP1 ARID1B ZFHX4 MTUS1 ATXN1 BAZ2A SETD5 GLI3 MCM3AP ZBTB21 FMN2 ANKRD17 IRS2 AFF4 RAI1 TP73 | 4.21e-13 | 1116 | 163 | 28 | 31753913 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SETD1A NCOA6 SYNPO2 EP400 RBBP6 CSAG1 NUMA1 SCYL1 BCL9 SH2B1 ARHGAP6 KLF5 TONSL UNK SPEN GAB1 TP73 | 2.48e-11 | 430 | 163 | 17 | 35044719 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 SETD1A NCOA6 EP400 PHF12 RTTN KSR2 MYOM3 MAML1 AMBRA1 PPP6R1 BCL9 ARID1A JAK3 SLC2A4RG PSME4 SETD5 MCM3AP NAV1 IRS2 DOT1L SNAPC4 SPEN AGRN RAI1 | 7.80e-11 | 1105 | 163 | 25 | 35748872 |
| Pubmed | SETD1A NCOA6 GAK TCF20 EP400 RBBP6 NUMA1 ARID1A PDLIM5 ARID1B BAZ2A OSBPL9 DLG1 RPRD2 PKN2 DOT1L AMOTL2 SPEN | 1.32e-10 | 549 | 163 | 18 | 38280479 | |
| Pubmed | 2.13e-10 | 83 | 163 | 9 | 28794006 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | GAK HIVEP1 EP400 RBBP6 MAML1 PPP6R1 ZCCHC2 ARID1A KIAA1217 MCM3AP TONSL NAV1 UNK YY1AP1 DOT1L SPEN GAB1 TP73 | 3.97e-10 | 588 | 163 | 18 | 38580884 |
| Pubmed | SETD1A NCOA6 EP400 PHF12 MAML1 AMBRA1 SYNPO LRCH1 ARID1B PSME4 MTUS1 ZBTB21 ANKRD17 UNK RPRD2 AMOTL2 RAI1 | 6.01e-10 | 529 | 163 | 17 | 14621295 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 NCOA6 HIVEP1 TCF20 SAMD4B NCKIPSD USP43 E2F8 VPS13D MTUS1 ATXN1 KIAA1217 ZBTB21 OSBPL8 NAV1 FMN2 ANKRD17 IRS2 SH3RF3 GAB1 | 4.62e-09 | 861 | 163 | 20 | 36931259 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SETD1A NCOA6 TCF20 EP400 RBBP6 SCYL1 ARID1A ARID1B BAZ2A MCM3AP YY1AP1 SPEN AFF4 | 9.28e-09 | 341 | 163 | 13 | 32971831 |
| Pubmed | TBX15 HIVEP1 TCF12 TCF20 ZNF280D ZKSCAN8 SIX4 ARID1A RFX2 ATF2 PDLIM5 TFDP1 ATXN1 BAZ2A KLF5 GLI3 ZBTB21 UNK SNAPC4 | 9.50e-09 | 808 | 163 | 19 | 20412781 | |
| Pubmed | TANC2 IRF2BP2 NCOA6 MXRA5 HIVEP1 TCF20 PHF12 MAML1 BCL9 ARID1A PARP4 ARID1B OTUD4 ANKRD17 IRS2 SPEN RAI1 | 9.82e-09 | 638 | 163 | 17 | 31182584 | |
| Pubmed | 1.61e-08 | 7 | 163 | 4 | 30366904 | ||
| Pubmed | TANC2 BCL9L HDAC6 SAMD4B NCKIPSD PPP6R1 ARID1A LRCH1 ARID1B NAV1 UNK IRS2 AMOTL2 SH3RF3 | 2.83e-08 | 446 | 163 | 14 | 24255178 | |
| Pubmed | TANC2 DMXL2 TCF20 ZNF618 KSR2 NUMA1 SYNPO PPP6R1 BCL9 DNAJC6 LRIG2 KIAA1217 ZBTB21 NAV1 OTUD4 ANKRD17 DLG1 AGRN AFF4 RAI1 | 2.96e-08 | 963 | 163 | 20 | 28671696 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 TCF20 ZNF280D PHF12 NUMA1 ZKSCAN8 SYNPO POLA2 TFDP1 BAZ2A ZBTB21 DOT1L SNAPC4 SPEN AFF4 RAI1 | 3.25e-08 | 608 | 163 | 16 | 36089195 |
| Pubmed | TBX15 HIVEP1 TCF12 TCF20 ZKSCAN8 SIX4 ARID1A ATF2 PDLIM5 TFDP1 IKZF4 BAZ2A KLF5 GLI3 PAX3 NPAS4 PYGO1 | 4.54e-08 | 709 | 163 | 17 | 22988430 | |
| Pubmed | NCOA6 TCF20 DSC3 EP400 SIX4 ARID1A TFG LRCH1 NECAP1 TFRC ARID1B OSBPL9 OSBPL8 RPRD2 | 5.69e-08 | 472 | 163 | 14 | 38943005 | |
| Pubmed | 8.72e-08 | 78 | 163 | 7 | 28611094 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TANC2 TCF12 HDAC6 SAMD4B NCKIPSD SCYL1 MAML1 PPP6R1 POLA2 LRCH1 PDLIM5 HROB SHROOM1 KLF5 KIAA1217 MCM3AP OTUD4 RPRD2 IRS2 AMOTL2 | 9.97e-08 | 1038 | 163 | 20 | 26673895 |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 2.47e-07 | 134 | 163 | 8 | 25452129 | |
| Pubmed | IRF2BP2 NCOA6 HIVEP1 TCF12 TCF20 EP400 PHF12 BCL7B MAML1 BCL9 ARID1A ATF2 INO80D E2F8 ARID1B KLF5 ZBTB21 SPEN MNDA RAI1 | 2.62e-07 | 1103 | 163 | 20 | 34189442 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | IRF2BP2 BCL9L NCOA6 TCF20 MAML1 BCL9 ARID1A TFG PARP4 ARID1B MCM3AP ANKRD17 RAI1 | 2.78e-07 | 457 | 163 | 13 | 32344865 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | HIVEP1 TCF20 EP400 NCKIPSD MAML1 NLRP1 SIX4 ARID1A ARID1B ZFHX4 YY1AP1 DOT1L | 4.40e-07 | 398 | 163 | 12 | 35016035 |
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 28174279 | ||
| Pubmed | SYNPO2 HIVEP1 TCF20 RBBP6 SYNPO MUC12 ATXN1 MCM3AP NAV1 ANKRD17 YY1AP1 GAB1 PYGO1 | 5.56e-07 | 486 | 163 | 13 | 20936779 | |
| Pubmed | TCF20 EP400 PPP6R1 DNAJC6 BAZ2A SETD5 MCM3AP NAV1 OTUD4 YY1AP1 SPEN TET3 | 5.57e-07 | 407 | 163 | 12 | 12693553 | |
| Pubmed | 5.93e-07 | 103 | 163 | 7 | 32744500 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EP400 PHF12 ZKSCAN8 SIX4 PDLIM5 TFDP1 ZFHX4 ATXN1 BAZ2A TONSL ZBTB21 OTUD4 PAX3 TP73 | 7.28e-07 | 583 | 163 | 14 | 29844126 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TBX15 TCF12 TCF20 MAML1 RFX2 ATF2 TFDP1 E2F8 GLI3 TONSL MYOCD PAX3 SNAPC4 SPEN RAI1 TP73 PYGO1 | 8.92e-07 | 877 | 163 | 17 | 20211142 |
| Pubmed | TCF12 EP400 SAMD4B PPP6R1 ARID1A ZFHX4 GLI3 AMOTL2 SPEN TP73 | 9.70e-07 | 282 | 163 | 10 | 23667531 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 1.00e-06 | 5 | 163 | 3 | 32808927 | |
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 1.00e-06 | 5 | 163 | 3 | 30760710 | |
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 15574752 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 2.00e-06 | 6 | 163 | 3 | 25184676 | |
| Pubmed | AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation. | 2.00e-06 | 6 | 163 | 3 | 25417107 | |
| Pubmed | GAK TCF20 EP400 MAML1 TFG PDLIM5 SLC4A2 TFRC ARID1B OSBPL8 NAV1 UNK DLG1 RPRD2 N4BP1 | 2.10e-06 | 733 | 163 | 15 | 34672954 | |
| Pubmed | 2.12e-06 | 20 | 163 | 4 | 32079660 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.72e-06 | 184 | 163 | 8 | 32908313 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF12 HDAC6 EP400 MAML1 COP1 PPP6R1 SIX4 RFX2 ATF2 SH2B1 TFDP1 ZFHX4 ZBTB21 ANKRD17 PAX3 SPEN | 3.07e-06 | 857 | 163 | 16 | 25609649 |
| Pubmed | HIVEP1 TCF20 ZNF280D PHF12 PPP6R1 TFDP1 ZFHX4 ZBTB21 NAV1 ANKRD17 IRS2 | 4.96e-06 | 418 | 163 | 11 | 34709266 | |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 21873227 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DYM ERV3-1 SAMD4B KSR2 EVC SYNPO ARID1A SH2B1 ARHGAP6 ATXN1 SETD5 KIAA1217 OSBPL9 NAV1 ANKRD17 DLG1 RPRD2 SH3RF3 TET3 AFF4 RAI1 | 6.97e-06 | 1489 | 163 | 21 | 28611215 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.26e-06 | 283 | 163 | 9 | 30585729 | |
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 37805104 | ||
| Pubmed | Genetics of shoulder girdle formation: roles of Tbx15 and aristaless-like genes. | 8.32e-06 | 9 | 163 | 3 | 15728667 | |
| Pubmed | Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo. | 8.32e-06 | 9 | 163 | 3 | 17098221 | |
| Pubmed | 1.01e-05 | 29 | 163 | 4 | 19279220 | ||
| Pubmed | DMXL2 TCF12 SAMD4B AMBRA1 PPP6R1 SLC4A2 PARP4 PSME4 TONSL ANKRD17 DLG1 YY1AP1 AGRN | 1.31e-05 | 650 | 163 | 13 | 38777146 | |
| Pubmed | ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. | 2.18e-05 | 2 | 163 | 2 | 35167193 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12652298 | ||
| Pubmed | Auxilin depletion causes self-assembly of clathrin into membraneless cages in vivo. | 2.18e-05 | 2 | 163 | 2 | 18489706 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21632100 | ||
| Pubmed | B7-DC (PD-L2) costimulation of CD4+ T-helper 1 response via RGMb. | 2.18e-05 | 2 | 163 | 2 | 28479601 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15371335 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 2.18e-05 | 2 | 163 | 2 | 37611161 | |
| Pubmed | Characterization of the interactions of human ZIC3 mutants with GLI3. | 2.18e-05 | 2 | 163 | 2 | 17764085 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32791957 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21242887 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 34910522 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 2.18e-05 | 2 | 163 | 2 | 28967863 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22484910 | ||
| Pubmed | A phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules. | 2.18e-05 | 2 | 163 | 2 | 24205348 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33767438 | ||
| Pubmed | B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. | 2.18e-05 | 2 | 163 | 2 | 11283156 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 34386776 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23202128 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33890484 | ||
| Pubmed | Disruption of GLI3-ZIC3 interaction in the cadmium-induced omphalocele chick model. | 2.18e-05 | 2 | 163 | 2 | 21069353 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30787326 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11687802 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 2.18e-05 | 2 | 163 | 2 | 24562383 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38811552 | ||
| Pubmed | Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2). | 2.18e-05 | 2 | 163 | 2 | 17024248 | |
| Pubmed | Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription. | 2.18e-05 | 2 | 163 | 2 | 28134250 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32268790 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 2.18e-05 | 2 | 163 | 2 | 29890703 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24788099 | ||
| Pubmed | Decoding of methylated histone H3 tail by the Pygo-BCL9 Wnt signaling complex. | 2.18e-05 | 2 | 163 | 2 | 18498752 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33052929 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25805831 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20682801 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24752301 | ||
| Pubmed | DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression. | 2.18e-05 | 2 | 163 | 2 | 30445206 | |
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 2.18e-05 | 2 | 163 | 2 | 27562491 | |
| Pubmed | 3.43e-05 | 339 | 163 | 9 | 30415952 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IRF2BP2 GAK EP400 RBBP6 NUMA1 PPP6R1 PDLIM5 BAZ2A KIAA1217 ZBTB21 ANKRD17 RPRD2 PKN2 IRS2 AFF4 | 3.66e-05 | 934 | 163 | 15 | 33916271 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 TCF20 EP400 RBBP6 PHF12 NUMA1 ZKSCAN8 SIX4 ARID1A ATF2 INO80D BAZ2A KLF5 TONSL RPRD2 SPEN TET3 RAI1 | 3.96e-05 | 1294 | 163 | 18 | 30804502 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 5.57e-05 | 361 | 163 | 9 | 30344098 | |
| Pubmed | 5.79e-05 | 281 | 163 | 8 | 24163370 | ||
| Pubmed | Pygopus residues required for its binding to Legless are critical for transcription and development. | 6.53e-05 | 3 | 163 | 2 | 14612447 | |
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 6.53e-05 | 3 | 163 | 2 | 30801007 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 21647563 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 8005021 | ||
| Pubmed | Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. | 6.53e-05 | 3 | 163 | 2 | 15121872 | |
| Pubmed | Preaxial polydactyly caused by Gli3 haploinsufficiency is rescued by Zic3 loss of function in mice. | 6.53e-05 | 3 | 163 | 2 | 22234993 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 34545187 | ||
| Interaction | TBXT interactions | IRF2BP2 NCOA6 HIVEP1 TCF20 BCL7B MAML1 SIX4 BCL9 ARID1A ARID1B ZFHX4 ATXN1 DOT1L SPEN | 3.76e-13 | 116 | 158 | 14 | int:TBXT |
| Interaction | SP7 interactions | IRF2BP2 BCL9L NCOA6 HIVEP1 TCF20 EP400 RBBP6 BCL7B MAML1 PROSER1 SIX4 BCL9 ARID1A ARID1B ZFHX4 ATXN1 RPRD2 N4BP1 PYGO1 | 3.38e-12 | 304 | 158 | 19 | int:SP7 |
| Interaction | TLE3 interactions | TBX15 IRF2BP2 BCL9L HIVEP1 TCF12 TCF20 RBBP6 MAML1 PROSER1 SIX4 BCL9 ARID1A INO80D ARID1B ATXN1 KLF5 MCM3AP OTUD4 DOT1L SPEN | 1.66e-11 | 376 | 158 | 20 | int:TLE3 |
| Interaction | FEV interactions | SETD1A NCOA6 HIVEP1 TCF20 EP400 PHF12 BCL7B MAML1 SIX4 BCL9 ARID1A ARID1B ZFHX4 ATXN1 YY1AP1 | 6.90e-11 | 203 | 158 | 15 | int:FEV |
| Interaction | EGR2 interactions | BCL9L NCOA6 HIVEP1 EP400 PHF12 MAML1 PROSER1 SIX4 BCL9 ARID1A ARID1B ZFHX4 ATXN1 | 9.52e-10 | 171 | 158 | 13 | int:EGR2 |
| Interaction | SMG7 interactions | IRF2BP2 NCOA6 HIVEP1 TCF20 SAMD4B MAML1 SIX4 BCL9 ARID1A ARID1B OTUD4 ANKRD17 UNK RPRD2 DOT1L SNAPC4 | 4.63e-09 | 319 | 158 | 16 | int:SMG7 |
| Interaction | CRX interactions | BCL9L TCF20 EP400 BCL7B MAML1 PROSER1 BCL9 ARID1A TFG ARID1B ZFHX4 ATXN1 SPEN RAI1 | 1.36e-08 | 254 | 158 | 14 | int:CRX |
| Interaction | SOX2 interactions | IRF2BP2 BCL9L NCOA6 HIVEP1 TCF12 TCF20 DSC3 EP400 SAMD4B KSR2 BCL7B NUMA1 MAML1 COP1 CP PROSER1 PPP6R1 EYA1 SIX4 BCL9 ARID1A PARP4 ARID1B ZFHX4 ATXN1 KLF5 GLI3 KIAA1217 ANKRD17 AMOTL2 SPEN TP73 | 4.99e-08 | 1422 | 158 | 32 | int:SOX2 |
| Interaction | AR interactions | MAGEA2 IRF2BP2 BCL9L NCOA6 GAK HIVEP1 TCF20 EP400 PHF12 BCL7B NUMA1 MAML1 BCL9 ARID1A ATF2 ARID1B ATXN1 KLF5 GLI3 KIAA1217 TONSL ZBTB21 RPRD2 DOT1L AFF4 RAI1 | 5.84e-08 | 992 | 158 | 26 | int:AR |
| Interaction | PAX9 interactions | BCL9L NCOA6 TCF20 MAML1 PROSER1 BCL9 ARID1A ARID1B ZFHX4 ATXN1 | 7.84e-08 | 130 | 158 | 10 | int:PAX9 |
| Interaction | ASF1A interactions | IRF2BP2 NCOA6 HIVEP1 TCF20 EP400 NUMA1 ARID1A ARID1B TONSL DOT1L SPEN RAI1 TP73 | 8.65e-08 | 249 | 158 | 13 | int:ASF1A |
| Interaction | PAX6 interactions | IRF2BP2 NCOA6 HIVEP1 EP400 PHF12 BCL7B SIX4 BCL9 ARID1A TFDP1 ARID1B ZFHX4 ATXN1 DLG1 TP73 | 2.03e-07 | 366 | 158 | 15 | int:PAX6 |
| Interaction | NFIX interactions | IRF2BP2 SETD1A HIVEP1 EP400 PHF12 SIX4 ARID1A TFDP1 ARID1B ZFHX4 ATXN1 SPEN | 2.42e-07 | 227 | 158 | 12 | int:NFIX |
| Interaction | TBR1 interactions | 2.65e-07 | 113 | 158 | 9 | int:TBR1 | |
| Interaction | YWHAZ interactions | TANC2 DMXL2 SYNPO2 HIVEP1 HDAC6 DSC3 SAMD4B KSR2 NCKIPSD USP43 COP1 SYNPO ARID1A TFG LRCH1 E2F8 VPS13D MTUS1 ATXN1 ZBTB21 OSBPL8 NAV1 OTUD4 ANKRD17 UNK FAM124A IRS2 GAB1 GP5 | 3.86e-07 | 1319 | 158 | 29 | int:YWHAZ |
| Interaction | KLF5 interactions | NCOA6 HIVEP1 EP400 PHF12 BCL7B MAML1 BCL9 ARID1A ARID1B ATXN1 KLF5 | 4.10e-07 | 195 | 158 | 11 | int:KLF5 |
| Interaction | WWTR1 interactions | NCOA6 GAK TCF20 EP400 NUMA1 ARID1A PDLIM5 ARID1B KLF5 OSBPL9 DLG1 RPRD2 PKN2 PAX3 AMOTL2 | 1.23e-06 | 422 | 158 | 15 | int:WWTR1 |
| Interaction | TLX1 interactions | IRF2BP2 HIVEP1 TCF20 MAML1 SIX4 BCL9 ARID1A ARID1B ZFHX4 PYGO1 | 1.24e-06 | 175 | 158 | 10 | int:TLX1 |
| Interaction | YWHAG interactions | TANC2 NCOA6 SYNPO2 HIVEP1 SAMD4B KSR2 NCKIPSD USP43 SYNPO ATF2 E2F8 VPS13D SHROOM1 MTUS1 ATXN1 ZBTB21 OSBPL8 NAV1 FMN2 ANKRD17 UNK FAM124A PKN2 IRS2 AMOTL2 SH3RF3 GAB1 | 1.41e-06 | 1248 | 158 | 27 | int:YWHAG |
| Interaction | ERG interactions | NCOA6 HIVEP1 TCF20 BCL7B NUMA1 MAML1 BCL9 ARID1A ARID1B ZFHX4 ATXN1 | 1.54e-06 | 223 | 158 | 11 | int:ERG |
| Interaction | NFIB interactions | 1.83e-06 | 142 | 158 | 9 | int:NFIB | |
| Interaction | LHX2 interactions | BCL9L HIVEP1 EP400 BCL7B BCL9 ARID1A ARID1B ZFHX4 ATXN1 PYGO1 | 1.87e-06 | 183 | 158 | 10 | int:LHX2 |
| Interaction | BAG2 interactions | IRF2BP2 SETD1A NCOA6 GAK TCF20 PHF12 AMBRA1 DNAJC6 PDLIM5 TFRC JAK3 VPS13D SHROOM1 ATXN1 OTUD4 RPRD2 DOT1L SPEN | 1.95e-06 | 622 | 158 | 18 | int:BAG2 |
| Interaction | LHX3 interactions | HIVEP1 TCF20 BCL7B SIX4 BCL9 ARID1A PDLIM5 ARID1B ZFHX4 ATXN1 | 2.06e-06 | 185 | 158 | 10 | int:LHX3 |
| Interaction | HNF1B interactions | HIVEP1 EP400 MAML1 PROSER1 SIX4 BCL9 ARID1A ARID1B ZFHX4 ATXN1 | 2.62e-06 | 190 | 158 | 10 | int:HNF1B |
| Interaction | PAX8 interactions | 2.66e-06 | 111 | 158 | 8 | int:PAX8 | |
| Interaction | SNRNP40 interactions | BCL9L HIVEP1 TCF12 TCF20 ZNF280D EP400 RBBP6 PHF12 NUMA1 BCL9 ARID1A TFDP1 ARID1B BAZ2A TONSL ZBTB21 DOT1L SPEN | 2.73e-06 | 637 | 158 | 18 | int:SNRNP40 |
| Interaction | TOP3B interactions | TANC2 SETD1A NCOA6 EP400 PHF12 SAMD4B RTTN KSR2 MYOM3 MAML1 AMBRA1 PPP6R1 BCL9 ARID1A JAK3 SLC2A4RG PSME4 SETD5 MCM3AP NAV1 OTUD4 ANKRD17 UNK IRS2 DOT1L SNAPC4 SPEN AGRN RAI1 | 3.43e-06 | 1470 | 158 | 29 | int:TOP3B |
| Interaction | ETS1 interactions | 5.08e-06 | 121 | 158 | 8 | int:ETS1 | |
| Interaction | YWHAH interactions | TANC2 NCOA6 HIVEP1 TCF20 SAMD4B KSR2 NCKIPSD USP43 POLA2 E2F8 VPS13D SHROOM1 MTUS1 ATXN1 KIAA1217 ZBTB21 OSBPL8 NAV1 FMN2 ANKRD17 IRS2 AMOTL2 SH3RF3 GAB1 | 5.26e-06 | 1102 | 158 | 24 | int:YWHAH |
| Interaction | HDAC1 interactions | HIVEP1 TCF20 EP400 PHF12 USP43 PPP6R1 ARID1A DNAJC6 PDLIM5 TFDP1 ZFHX4 ATXN1 BAZ2A KLF5 GLI3 ZBTB21 NAV1 ANKRD17 IRS2 PAX3 DOT1L SPEN RAI1 TP73 | 5.76e-06 | 1108 | 158 | 24 | int:HDAC1 |
| Interaction | PAX7 interactions | 6.09e-06 | 124 | 158 | 8 | int:PAX7 | |
| Interaction | NUP35 interactions | IRF2BP2 BCL9L NCOA6 TCF20 NUMA1 MAML1 BCL9 ARID1A TFG PARP4 ARID1B MCM3AP ANKRD17 RAI1 | 6.58e-06 | 424 | 158 | 14 | int:NUP35 |
| Interaction | LHX4 interactions | 6.60e-06 | 166 | 158 | 9 | int:LHX4 | |
| Interaction | SOX10 interactions | 7.99e-06 | 92 | 158 | 7 | int:SOX10 | |
| Interaction | NUP43 interactions | BCL9L SETD1A NCOA6 HIVEP1 TCF20 ZNF280D EP400 RBBP6 PHF12 CCDC168 ARID1A TFDP1 ARID1B BAZ2A MCM3AP TONSL SPEN | 8.67e-06 | 625 | 158 | 17 | int:NUP43 |
| Interaction | HNF4A interactions | IRF2BP2 SETD1A NCOA6 HIVEP1 EP400 PHF12 ARID1A ARID1B ATXN1 ZBTB21 SPEN | 1.14e-05 | 275 | 158 | 11 | int:HNF4A |
| Interaction | SMAD3 interactions | NCOA6 HIVEP1 TCF12 ARID1A LRCH1 ATF2 PDLIM5 PARP4 ARID1B KLF5 GLI3 MCM3AP MYOCD TP73 | 1.19e-05 | 447 | 158 | 14 | int:SMAD3 |
| Interaction | KLF3 interactions | IRF2BP2 SETD1A HIVEP1 EP400 PHF12 ARID1A TFDP1 TFRC ARID1B ATXN1 | 1.31e-05 | 228 | 158 | 10 | int:KLF3 |
| Interaction | YWHAB interactions | TANC2 HIVEP1 SAMD4B KSR2 NCKIPSD USP43 COP1 ATF2 PDLIM5 E2F8 VPS13D SHROOM1 ATXN1 ZBTB21 NAV1 ANKRD17 UNK IRS2 DOT1L AMOTL2 SH3RF3 GAB1 | 1.44e-05 | 1014 | 158 | 22 | int:YWHAB |
| Interaction | NUP50 interactions | SETD1A HDAC6 TCF20 RBBP6 BCL7B ARID1A BAZ2A MCM3AP DLG1 RPRD2 SPEN RAI1 | 1.64e-05 | 341 | 158 | 12 | int:NUP50 |
| Interaction | NFIA interactions | 1.80e-05 | 188 | 158 | 9 | int:NFIA | |
| Interaction | TLX3 interactions | TBX15 BCL9L NCOA6 HIVEP1 TCF20 MAML1 PROSER1 BCL9 ARID1A ARID1B ZFHX4 | 1.94e-05 | 291 | 158 | 11 | int:TLX3 |
| Interaction | PPIA interactions | CACNA1D NCOA6 HDAC6 TCF20 DSC3 EP400 BCL7B SIX4 ARID1A TFG LRCH1 NECAP1 SLC4A2 TFRC ARID1B PTPRN OSBPL9 OSBPL8 RPRD2 KLB | 2.15e-05 | 888 | 158 | 20 | int:PPIA |
| Interaction | GATA2 interactions | 2.81e-05 | 199 | 158 | 9 | int:GATA2 | |
| Interaction | TERF2IP interactions | SETD1A NCOA6 HIVEP1 TCF20 EP400 RBBP6 BCL7B NUMA1 ARID1A POLA2 BAZ2A ZBTB21 SPEN AFF4 RAI1 | 3.05e-05 | 552 | 158 | 15 | int:TERF2IP |
| Interaction | CT45A5 interactions | 3.40e-05 | 78 | 158 | 6 | int:CT45A5 | |
| Interaction | FOS interactions | NCOA6 HIVEP1 TCF12 EP400 COP1 BCL9 ARID1A ATF2 TFDP1 ARID1B ANKRD17 | 3.67e-05 | 312 | 158 | 11 | int:FOS |
| Interaction | ELK3 interactions | 4.52e-05 | 120 | 158 | 7 | int:ELK3 | |
| Interaction | SOX7 interactions | 4.52e-05 | 82 | 158 | 6 | int:SOX7 | |
| Interaction | GSC interactions | 6.32e-05 | 87 | 158 | 6 | int:GSC | |
| Interaction | TEAD1 interactions | 7.63e-05 | 176 | 158 | 8 | int:TEAD1 | |
| Interaction | SOX17 interactions | 1.03e-04 | 95 | 158 | 6 | int:SOX17 | |
| Interaction | CEBPA interactions | IRF2BP2 NCOA6 HIVEP1 TCF12 TCF20 EP400 PHF12 BCL7B MAML1 COP1 BCL9 ARID1A ATF2 INO80D E2F8 ARID1B KLF5 ZBTB21 YY1AP1 PKN2 SPEN MNDA RAI1 | 1.09e-04 | 1245 | 158 | 23 | int:CEBPA |
| Interaction | SOX9 interactions | 1.16e-04 | 97 | 158 | 6 | int:SOX9 | |
| Interaction | FOXL1 interactions | 1.61e-04 | 196 | 158 | 8 | int:FOXL1 | |
| Interaction | LHX1 interactions | 1.61e-04 | 103 | 158 | 6 | int:LHX1 | |
| Interaction | PHIP interactions | 1.67e-04 | 197 | 158 | 8 | int:PHIP | |
| Interaction | GCM1 interactions | 1.95e-04 | 68 | 158 | 5 | int:GCM1 | |
| Interaction | SYNE3 interactions | TANC2 GAK TCF20 SAMD4B PROSER1 ZCCHC2 TFRC GLI3 KIAA1217 OSBPL8 NAV1 UNK | 2.05e-04 | 444 | 158 | 12 | int:SYNE3 |
| Interaction | ETV4 interactions | 2.09e-04 | 69 | 158 | 5 | int:ETV4 | |
| Interaction | PRR20A interactions | 2.20e-04 | 109 | 158 | 6 | int:PRR20A | |
| Interaction | NR3C1 interactions | TANC2 IRF2BP2 NCOA6 MXRA5 HIVEP1 HDAC6 TCF20 PHF12 MAML1 BCL9 ARID1A TFRC PARP4 ARID1B OTUD4 ANKRD17 IRS2 SPEN RAI1 | 2.31e-04 | 974 | 158 | 19 | int:NR3C1 |
| Interaction | SOCS3 interactions | 2.31e-04 | 110 | 158 | 6 | int:SOCS3 | |
| Interaction | HECW2 interactions | 2.34e-04 | 322 | 158 | 10 | int:HECW2 | |
| Interaction | LPIN3 interactions | 2.72e-04 | 73 | 158 | 5 | int:LPIN3 | |
| Interaction | CREBBP interactions | SETD1A NCOA6 GAK HIVEP1 TCF12 MAML1 ARID1A ATF2 TFDP1 ARID1B ATXN1 KLF5 GLI3 TP73 | 2.73e-04 | 599 | 158 | 14 | int:CREBBP |
| Interaction | CIC interactions | EP400 PHF12 ZKSCAN8 SIX4 PDLIM5 TFDP1 ZFHX4 ATXN1 BAZ2A KLF5 TONSL ZBTB21 OTUD4 PAX3 TP73 | 2.73e-04 | 673 | 158 | 15 | int:CIC |
| Interaction | ISL2 interactions | 2.94e-04 | 41 | 158 | 4 | int:ISL2 | |
| Interaction | SMARCA4 interactions | EP400 BCL7B NUMA1 SCYL1 MAML1 EYA1 ARID1A ARID1B ATXN1 GLI3 MYOCD DOT1L | 2.94e-04 | 462 | 158 | 12 | int:SMARCA4 |
| Interaction | LDB1 interactions | 2.94e-04 | 115 | 158 | 6 | int:LDB1 | |
| Interaction | YWHAE interactions | TANC2 HIVEP1 HDAC6 SAMD4B KSR2 NCKIPSD USP43 LRCH1 E2F8 ATXN1 ZBTB21 OSBPL8 NAV1 ANKRD17 UNK FAM124A IRS2 DOT1L AMOTL2 SH3RF3 AGRN GAB1 | 3.29e-04 | 1256 | 158 | 22 | int:YWHAE |
| Interaction | CAMKV interactions | 3.38e-04 | 118 | 158 | 6 | int:CAMKV | |
| Interaction | GPR155 interactions | 3.63e-04 | 4 | 158 | 2 | int:GPR155 | |
| Interaction | DDIT3 interactions | 3.70e-04 | 120 | 158 | 6 | int:DDIT3 | |
| Interaction | TWIST1 interactions | 3.94e-04 | 170 | 158 | 7 | int:TWIST1 | |
| Interaction | KDM1A interactions | HIVEP1 HDAC6 TCF20 ZNF280D EP400 PHF12 PPP6R1 DNAJC6 TFDP1 ZFHX4 ATXN1 KIAA1217 ZBTB21 NAV1 ANKRD17 UNK IRS2 TP73 | 4.29e-04 | 941 | 158 | 18 | int:KDM1A |
| Interaction | SMARCE1 interactions | 4.49e-04 | 287 | 158 | 9 | int:SMARCE1 | |
| Interaction | HDAC2 interactions | IRF2BP2 TCF20 EP400 PHF12 NCKIPSD USP43 ARID1A TFDP1 IKZF4 TFRC KLF5 ANKRD17 UNK RPRD2 SPEN RAI1 TP73 | 4.60e-04 | 865 | 158 | 17 | int:HDAC2 |
| Interaction | YWHAQ interactions | TANC2 NCOA6 HDAC6 ZNF280D SAMD4B KSR2 NCKIPSD NUMA1 USP43 E2F8 VPS13D SHROOM1 MTUS1 ATXN1 ZBTB21 NAV1 ANKRD17 IRS2 AMOTL2 GAB1 | 4.81e-04 | 1118 | 158 | 20 | int:YWHAQ |
| Interaction | DAXX interactions | 4.84e-04 | 353 | 158 | 10 | int:DAXX | |
| Interaction | BRD3 interactions | RBBP6 ZNF618 NUMA1 ARID1A INO80D TFDP1 ATXN1 SETD5 TONSL UNK DOT1L RAI1 | 5.35e-04 | 494 | 158 | 12 | int:BRD3 |
| Interaction | PAX2 interactions | 5.50e-04 | 85 | 158 | 5 | int:PAX2 | |
| Interaction | CBX3 interactions | SETD1A TCF20 ZNF280D EP400 RBBP6 NUMA1 SIX4 PDLIM5 TFDP1 NECAP1 BAZ2A ZBTB21 UNK SPEN | 5.79e-04 | 646 | 158 | 14 | int:CBX3 |
| Interaction | ALG13 interactions | 6.12e-04 | 183 | 158 | 7 | int:ALG13 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.19e-04 | 161 | 103 | 6 | 593 | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 6.63e-04 | 7 | 103 | 2 | 570 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 8.80e-04 | 8 | 103 | 2 | 658 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 8.80e-04 | 8 | 103 | 2 | 837 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.13e-03 | 9 | 103 | 2 | 1280 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.16e-03 | 206 | 103 | 6 | 682 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 2.04e-03 | 12 | 103 | 2 | 670 | |
| GeneFamily | Fibronectin type III domain containing | 2.22e-03 | 160 | 103 | 5 | 555 | |
| GeneFamily | AT-rich interaction domain containing | 3.22e-03 | 15 | 103 | 2 | 418 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | ICOSLG DMXL2 TCF20 MFSD6 NCKIPSD INO80D PDLIM5 OTUD4 ANKRD17 DLG1 AFF4 | 1.11e-06 | 269 | 164 | 11 | M41203 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DMXL2 HIVEP1 TCF12 ATF2 PDLIM5 TGFBR3 ELL2 PSME4 LRIG1 ATXN1 OSBPL8 OTUD4 ANKRD17 DLG1 PKN2 N4BP1 SPEN PHLPP2 | 7.49e-06 | 856 | 164 | 18 | M4500 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TBX15 RGMB TCF12 TCF20 OLFML2B PHF12 EYA1 ARID1A SLC4A2 PARP4 LRIG1 ATXN1 KLF5 KIAA1217 NAV1 ANKRD17 PKN2 ZNF488 PAX3 | 1.94e-05 | 1009 | 164 | 19 | M157 |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_UP | 3.30e-05 | 195 | 164 | 8 | M7694 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 3.82e-05 | 11 | 164 | 3 | M1358 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP | 3.82e-05 | 11 | 164 | 3 | MM569 | |
| Coexpression | GSE17721_0.5H_VS_4H_CPG_BMDC_DN | 3.95e-05 | 200 | 164 | 8 | M4125 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | TANC2 BCL9L MFSD6 NLRP1 EYA1 TGFBR3 KIAA1217 AMOTL2 SNAPC4 SPSB3 | 5.52e-05 | 337 | 164 | 10 | M13206 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | IRF2BP2 RGMB SYNPO2 RBBP6 ZKSCAN8 EYA1 DNAJC6 PDLIM5 ZFHX4 PROKR2 SETD5 PCDH11X OTUD4 RPRD2 MYOCD AGRN | 1.85e-07 | 427 | 162 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500 | IRF2BP2 RGMB ZKSCAN8 PDLIM5 SETD5 PCDH11X OTUD4 RPRD2 MYOCD AGRN | 5.72e-07 | 165 | 162 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | IRF2BP2 RGMB ZKSCAN8 EYA1 DNAJC6 ZFHX4 PROKR2 PCDH11X MYOCD AGRN | 1.15e-06 | 178 | 162 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | IRF2BP2 RGMB ZKSCAN8 PDLIM5 GLI3 PCDH11X OTUD4 RPRD2 MYOCD AGRN | 1.15e-06 | 178 | 162 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | CACNA1D RGMB SYNPO2 EYA1 SIX4 BCL9 ZFHX4 PROKR2 KLF5 PCDH11X FMN2 MYOCD AGRN PYGO1 | 3.05e-06 | 407 | 162 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TANC2 IRF2BP2 RGMB SYNPO2 TCF20 RBBP6 ZKSCAN8 EYA1 SIX4 DNAJC6 ATF2 PDLIM5 ZFHX4 PROKR2 SETD5 PCDH11X OTUD4 RPRD2 MYOCD AGRN | 4.45e-06 | 818 | 162 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 IRF2BP2 RGMB SYNPO2 ZNF618 ZKSCAN8 EYA1 BCL9 DNAJC6 TFRC ARHGAP6 ZFHX4 PROKR2 SETD5 GLI3 PCDH11X OTUD4 FMN2 MYOCD AGRN | 4.45e-06 | 818 | 162 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CACNA1D IRF2BP2 RGMB SYNPO2 DSC3 RBBP6 ZKSCAN8 SYNPO EYA1 BCL9 DNAJC6 ZFHX4 MICALL2 PROKR2 KLF5 GLI3 FMN2 PAX3 AGRN | 6.78e-06 | 769 | 162 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200 | 7.05e-06 | 61 | 162 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.52e-06 | 63 | 162 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | IRF2BP2 RGMB SYNPO2 RBBP6 ZKSCAN8 EYA1 SIX4 TFRC ARHGAP6 ZFHX4 PROKR2 SETD5 KLF5 PCDH11X OTUD4 FMN2 MYOCD AGRN PYGO1 | 1.31e-05 | 806 | 162 | 19 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TBX15 TANC2 IRF2BP2 SYNPO2 DSC3 ZKSCAN8 EYA1 SIX4 DNAJC6 ARHGAP6 ELL2 ZFHX4 LRIG1 PROKR2 OSBPL8 FMN2 RPRD2 PAX3 PYGO1 | 2.18e-05 | 836 | 162 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | IRF2BP2 RGMB SYNPO2 ZKSCAN8 PDLIM5 TFRC ARHGAP6 ZFHX4 ATXN1 PCDH11X OTUD4 MYOCD AGRN | 2.18e-05 | 421 | 162 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 2.93e-05 | 78 | 162 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TANC2 IRF2BP2 RGMB ZNF618 ZKSCAN8 BCL9 TFRC SETD5 GLI3 OTUD4 MYOCD AGRN | 4.16e-05 | 385 | 162 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | TANC2 IRF2BP2 RGMB ZKSCAN8 PDLIM5 SETD5 PCDH11X OTUD4 RPRD2 MYOCD AGRN | 4.80e-05 | 330 | 162 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | TANC2 IRF2BP2 RGMB SYNPO2 ZKSCAN8 PDLIM5 E2F8 TFRC ARHGAP6 ZFHX4 ATXN1 SETD5 GLI3 PCDH11X OTUD4 MYOCD AGRN PYGO1 | 4.94e-05 | 811 | 162 | 18 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | TANC2 IRF2BP2 RGMB ZKSCAN8 PDLIM5 TFRC SETD5 GLI3 PCDH11X OTUD4 MYOCD AGRN | 5.59e-05 | 397 | 162 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_100 | 6.19e-05 | 89 | 162 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 7.30e-05 | 231 | 162 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | GAK ZNF280D OLFML2B PHF12 ZKSCAN8 COP1 ARID1A TFG ATXN1 SETD5 GLI3 FMN2 DLG1 N4BP1 SPSB3 | 9.87e-05 | 629 | 162 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 1.27e-04 | 34 | 162 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | IRF2BP2 RGMB ZKSCAN8 SIX4 PDLIM5 TFRC KIAA1217 OTUD4 FMN2 PKN2 AGRN | 1.49e-04 | 375 | 162 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CACNA1D RGMB SYNPO2 EYA1 SIX4 BCL9 IKZF4 ZFHX4 PROKR2 KLF5 GLI3 PCDH11X OTUD4 FMN2 MYOCD AGRN PYGO1 | 1.49e-04 | 806 | 162 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_100 | 1.59e-04 | 36 | 162 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 1.59e-04 | 256 | 162 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.71e-04 | 203 | 162 | 8 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | IRF2BP2 RGMB SYNPO2 ZKSCAN8 ATF2 PDLIM5 IKZF4 ARHGAP6 ZFHX4 SETD5 GLI3 ZBTB21 PCDH11X OTUD4 RPRD2 MYOCD AGRN | 1.99e-04 | 826 | 162 | 17 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.08e-04 | 209 | 162 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 2.60e-04 | 163 | 162 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.86e-04 | 339 | 162 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | RGMB SYNPO2 TCF12 RTTN ZKSCAN8 PDLIM5 TFRC ZFHX4 ATXN1 PCDH11X OSBPL8 OTUD4 FMN2 MYOCD PKN2 AGRN | 2.86e-04 | 772 | 162 | 16 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | IRF2BP2 RGMB SYNPO2 ZKSCAN8 EYA1 ZFHX4 SETD5 PCDH11X OTUD4 MYOCD AGRN | 3.08e-04 | 408 | 162 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 3.48e-04 | 171 | 162 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 3.50e-04 | 122 | 162 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.73e-04 | 173 | 162 | 7 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 4.37e-04 | 83 | 162 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | IRF2BP2 RGMB ZKSCAN8 EYA1 TFRC SETD5 PCDH11X OTUD4 MYOCD AGRN | 5.56e-04 | 369 | 162 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | GPR155 ZNF280D MFSD6 ZKSCAN8 EYA1 BCL9 ARID1A ZFHX4 GLI3 MCM3AP TONSL PCDH11X NAV1 DLG1 N4BP1 STRC SH3RF3 SPSB3 | 5.65e-04 | 989 | 162 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_100 | 6.02e-04 | 89 | 162 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 6.49e-04 | 137 | 162 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 7.00e-04 | 92 | 162 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_100 | 7.00e-04 | 92 | 162 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 7.38e-04 | 194 | 162 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200 | 7.67e-04 | 54 | 162 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 7.72e-04 | 94 | 162 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 8.49e-04 | 390 | 162 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.44e-07 | 185 | 164 | 8 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.62e-07 | 186 | 164 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 5.22e-07 | 189 | 164 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.11e-07 | 193 | 164 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.41e-07 | 198 | 164 | 8 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.70e-07 | 199 | 164 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.61e-06 | 179 | 164 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 4.96e-06 | 181 | 164 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 164 | 7 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-06 | 184 | 164 | 7 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.59e-06 | 189 | 164 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 190 | 164 | 7 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 190 | 164 | 7 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.30e-06 | 192 | 164 | 7 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.08e-06 | 195 | 164 | 7 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-06 | 196 | 164 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.35e-06 | 196 | 164 | 7 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.35e-06 | 196 | 164 | 7 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.92e-06 | 198 | 164 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 9.22e-06 | 199 | 164 | 7 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 9.22e-06 | 199 | 164 | 7 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.22e-06 | 199 | 164 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.22e-06 | 199 | 164 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.09e-05 | 135 | 164 | 6 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-05 | 143 | 164 | 6 | 39060dc1d87505a16e2df95140087c731f099570 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.91e-05 | 149 | 164 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-05 | 153 | 164 | 6 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 156 | 164 | 6 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.66e-05 | 158 | 164 | 6 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-05 | 160 | 164 | 6 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 177 | 164 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.02e-05 | 177 | 164 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.18e-05 | 178 | 164 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 178 | 164 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.34e-05 | 179 | 164 | 6 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.68e-05 | 181 | 164 | 6 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-05 | 181 | 164 | 6 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-05 | 181 | 164 | 6 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.04e-05 | 183 | 164 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 183 | 164 | 6 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 184 | 164 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 184 | 164 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 184 | 164 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.22e-05 | 184 | 164 | 6 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | Control-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 6.41e-05 | 185 | 164 | 6 | 9a793e6016295a63820e9d7563f195494ac692e7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.41e-05 | 185 | 164 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.41e-05 | 185 | 164 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 7.01e-05 | 116 | 164 | 5 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 188 | 164 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 188 | 164 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.01e-05 | 188 | 164 | 6 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-05 | 188 | 164 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.01e-05 | 188 | 164 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-05 | 188 | 164 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.01e-05 | 188 | 164 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 189 | 164 | 6 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 189 | 164 | 6 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.43e-05 | 190 | 164 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.43e-05 | 190 | 164 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.43e-05 | 190 | 164 | 6 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.43e-05 | 190 | 164 | 6 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.43e-05 | 190 | 164 | 6 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | Severe-Lymphoid-NK-Treg|Severe / Condition, Lineage, Cell class and cell subclass | 7.43e-05 | 190 | 164 | 6 | e67803bf55a3f8e47a69ff1829c9100f870d7527 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 7.43e-05 | 190 | 164 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.65e-05 | 191 | 164 | 6 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 191 | 164 | 6 | 9d3fa8d8138700640cc7927521c7635299df697d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.65e-05 | 191 | 164 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 191 | 164 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.65e-05 | 191 | 164 | 6 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 191 | 164 | 6 | d04ed1e04b8cb904237d8e8388fe7740c724237b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 191 | 164 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.87e-05 | 192 | 164 | 6 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.87e-05 | 192 | 164 | 6 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.10e-05 | 193 | 164 | 6 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 8.10e-05 | 193 | 164 | 6 | 024d30eb143d8278c0851c3a6c9426226fa3b480 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-05 | 194 | 164 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.33e-05 | 194 | 164 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 194 | 164 | 6 | 0e315c63407fa00643722a7d6138b1502f79b10d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 194 | 164 | 6 | 588c45dafa00547b2506e298a2434b1b5e15560d | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 8.33e-05 | 194 | 164 | 6 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 194 | 164 | 6 | c2990d6eda3954dc01913bf3910df79f06e0010a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.33e-05 | 194 | 164 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.57e-05 | 195 | 164 | 6 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 195 | 164 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.57e-05 | 195 | 164 | 6 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.57e-05 | 195 | 164 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.57e-05 | 195 | 164 | 6 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.82e-05 | 196 | 164 | 6 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 9.06e-05 | 197 | 164 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.06e-05 | 197 | 164 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 197 | 164 | 6 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 9.06e-05 | 197 | 164 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 198 | 164 | 6 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.32e-05 | 198 | 164 | 6 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 198 | 164 | 6 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 198 | 164 | 6 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.32e-05 | 198 | 164 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 198 | 164 | 6 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.32e-05 | 198 | 164 | 6 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.58e-05 | 199 | 164 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; PC3; HT_HG-U133A | 1.45e-06 | 198 | 160 | 10 | 4550_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.02e-05 | 195 | 160 | 9 | 2875_UP | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | ICOSLG GPER1 NUMA1 AMBRA1 PROSER1 ARID1A ZFHX4 SNAPC4 MUC5AC | 1.06e-05 | 196 | 160 | 9 | 3256_UP |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 7520_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.06e-05 | 196 | 160 | 9 | 4342_UP | |
| Drug | AH6809; Up 200; 1uM; PC3; HT_HG-U133A | 1.11e-05 | 197 | 160 | 9 | 7049_UP | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 1489_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.20e-05 | 199 | 160 | 9 | 3403_DN | |
| Drug | Mn(III)TMPyP | 2.77e-05 | 9 | 160 | 3 | CID005486195 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.91e-05 | 171 | 160 | 8 | 7535_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 5.29e-05 | 186 | 160 | 8 | 4463_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.29e-05 | 186 | 160 | 8 | 916_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.92e-05 | 189 | 160 | 8 | 5248_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 6.14e-05 | 190 | 160 | 8 | 6956_UP | |
| Drug | rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 1233_DN | |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; HL60; HT_HG-U133A | 6.86e-05 | 193 | 160 | 8 | 2731_UP | |
| Drug | Nystatine [1400-61-9]; Up 200; 4.4uM; HL60; HT_HG-U133A | 7.37e-05 | 195 | 160 | 8 | 2500_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 7.64e-05 | 196 | 160 | 8 | 3416_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 5605_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 5643_DN | |
| Drug | Isometheptene mucate; Down 200; 8.2uM; HL60; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 3145_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; HL60; HT_HG-U133A | 7.92e-05 | 197 | 160 | 8 | 2205_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 6341_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 2211_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 4282_DN | |
| Drug | Butacaine [149-16-6]; Up 200; 13uM; MCF7; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 3469_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 8.20e-05 | 198 | 160 | 8 | 4316_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; HL60; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 2144_UP | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 160 | 8 | 5534_UP | |
| Drug | rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 6192_DN | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 8.80e-05 | 200 | 160 | 8 | 7229_DN | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Parkinson's disease 19A (implicated_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:0060891 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.30e-05 | 71 | 160 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | cutaneous Leishmaniasis | 8.32e-05 | 16 | 160 | 3 | EFO_0005046 | |
| Disease | mean corpuscular hemoglobin concentration | IRF2BP2 EP400 RTTN PPP6R1 PGAP6 SH2B1 E2F8 SLC4A2 TFRC ELL2 SLC2A4RG ATXN1 KIAA1217 OTUD4 PKN2 IRS2 DOT1L | 1.11e-04 | 1105 | 160 | 17 | EFO_0004528 |
| Disease | alcohol consumption measurement | CACNA1D SETD1A ZNF280D ZNF618 MFSD6 BCL7B INO80D SH2B1 NPIPB8 ATXN1 NPIPB6 GLI3 RPRD2 TET3 AGRN AFF4 PHLPP2 KLB | 1.46e-04 | 1242 | 160 | 18 | EFO_0007878 |
| Disease | testosterone measurement | CACNA1D IRF2BP2 NCOA6 TCF12 ZNF280D USP43 EYA1 ARID1A SH2B1 ARHGAP6 ARID1B SLC2A4RG ZFHX4 MYOCD YY1AP1 USH2A RAI1 RNF212B | 2.02e-04 | 1275 | 160 | 18 | EFO_0004908 |
| Disease | Iron Metabolism Disorders | 2.89e-04 | 5 | 160 | 2 | C0012715 | |
| Disease | Alveolar rhabdomyosarcoma | 2.89e-04 | 5 | 160 | 2 | C0206655 | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 2.89e-04 | 5 | 160 | 2 | C1275278 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.89e-04 | 5 | 160 | 2 | C3281201 | |
| Disease | Bare Lymphocyte Syndrome | 4.32e-04 | 6 | 160 | 2 | C0242583 | |
| Disease | mammographic density percentage | 5.15e-04 | 29 | 160 | 3 | EFO_0006502 | |
| Disease | pulse pressure measurement | CACNA1D MXRA5 ZNF618 ZCCHC2 ZNF831 LRCH1 PDLIM5 TGFBR3 FNDC1 ARID1B ZFHX4 LRIG1 ATXN1 KIAA1217 NAV1 PKN2 DOT1L KLB | 5.74e-04 | 1392 | 160 | 18 | EFO_0005763 |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 6.03e-04 | 7 | 160 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | cognitive function measurement | TANC2 CACNA1D IRF2BP2 DMXL2 SYNPO2 HIVEP1 TCF20 ZNF618 NCKIPSD POM121L2 ZCCHC2 SH2B1 ARID1B ATXN1 GLI3 KIAA1217 USH2A SH3RF3 | 8.09e-04 | 1434 | 160 | 18 | EFO_0008354 |
| Disease | Growth Disorders | 9.80e-04 | 36 | 160 | 3 | C0018273 | |
| Disease | Schizophrenia | SETD1A DYM AMBRA1 CP CMYA5 BCL9 PDLIM5 TYR KLF5 NAV1 DLG1 NPAS4 RAI1 | 1.09e-03 | 883 | 160 | 13 | C0036341 |
| Disease | diastolic blood pressure, systolic blood pressure | TBX15 CACNA1D SCYL1 MAML1 BCL9 LRCH1 PDLIM5 ARID1B LRIG1 NAV1 MYOCD | 1.12e-03 | 670 | 160 | 11 | EFO_0006335, EFO_0006336 |
| Disease | vital capacity | TBX15 NCOA6 TCF20 MFSD6 POM121L2 SIX4 SH2B1 SLC2A4RG GLI3 OTUD4 DLG1 RPRD2 DOT1L SNAPC4 NPAS4 GAB1 | 1.16e-03 | 1236 | 160 | 16 | EFO_0004312 |
| Disease | neuroblastoma (is_implicated_in) | 1.28e-03 | 10 | 160 | 2 | DOID:769 (is_implicated_in) | |
| Disease | forced expiratory volume | CACNA1D SETD1A RGMB NCOA6 POM121L2 BCL9 SH2B1 IKZF4 SLC2A4RG OTUD4 RPRD2 GAB1 | 1.29e-03 | 789 | 160 | 12 | EFO_0004314 |
| Disease | cervix uteri carcinoma in situ (is_marker_for) | 1.54e-03 | 42 | 160 | 3 | DOID:8991 (is_marker_for) | |
| Disease | Craniofacial Abnormalities | 1.65e-03 | 156 | 160 | 5 | C0376634 | |
| Disease | Liver carcinoma | 1.86e-03 | 507 | 160 | 9 | C2239176 | |
| Disease | alpha fetoprotein measurement | 2.18e-03 | 100 | 160 | 4 | EFO_0010583 | |
| Disease | Coffin-Siris syndrome | 2.19e-03 | 13 | 160 | 2 | C0265338 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.19e-03 | 13 | 160 | 2 | C1846647 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 2.19e-03 | 13 | 160 | 2 | OBA_2045174 | |
| Disease | anthropometric measurement | 2.28e-03 | 168 | 160 | 5 | EFO_0004302 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.40e-03 | 49 | 160 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | mammographic density measurement | 2.54e-03 | 50 | 160 | 3 | EFO_0005941 | |
| Disease | QRS amplitude, QRS complex | 2.54e-03 | 50 | 160 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | cognitive inhibition measurement | 2.54e-03 | 50 | 160 | 3 | EFO_0007969 | |
| Disease | aortic measurement | 2.55e-03 | 251 | 160 | 6 | EFO_0020865 | |
| Disease | HSV2 virologic severity measurement | 2.93e-03 | 15 | 160 | 2 | EFO_0009010 | |
| Disease | Situs ambiguus | 2.93e-03 | 15 | 160 | 2 | C0266642 | |
| Disease | bilirubin measurement | 2.94e-03 | 442 | 160 | 8 | EFO_0004570 | |
| Disease | grip strength measurement | 3.09e-03 | 350 | 160 | 7 | EFO_0006941 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.34e-03 | 355 | 160 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | migraine disorder | 3.44e-03 | 357 | 160 | 7 | MONDO_0005277 | |
| Disease | cancer (implicated_via_orthology) | 3.51e-03 | 268 | 160 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Multiple congenital anomalies | 3.77e-03 | 17 | 160 | 2 | C0000772 | |
| Disease | mean reticulocyte volume | SETD1A EP400 RTTN SH2B1 E2F8 TFRC PTPRN KIAA1217 TONSL OTUD4 IRS2 | 4.35e-03 | 799 | 160 | 11 | EFO_0010701 |
| Disease | Omenn Syndrome | 4.70e-03 | 19 | 160 | 2 | C2700553 | |
| Disease | Deaf Mutism | 5.21e-03 | 20 | 160 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 5.21e-03 | 20 | 160 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 5.21e-03 | 20 | 160 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 5.21e-03 | 20 | 160 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 5.21e-03 | 20 | 160 | 2 | C3665473 | |
| Disease | Severe Combined Immunodeficiency | 5.21e-03 | 20 | 160 | 2 | C0085110 | |
| Disease | Prelingual Deafness | 5.21e-03 | 20 | 160 | 2 | C0011052 | |
| Disease | body fat percentage | 5.31e-03 | 488 | 160 | 8 | EFO_0007800 | |
| Disease | optic disc size measurement | 5.31e-03 | 205 | 160 | 5 | EFO_0004832 | |
| Disease | Obesity | 5.31e-03 | 205 | 160 | 5 | C0028754 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKPTSQHYTNPTSNP | 86 | Q6N043 | |
| VPASPINFHPESRSS | 101 | Q6N043 | |
| HSPQPSPSSSFNEGL | 601 | Q9Y2J4 | |
| TVPQFEAPSPSHSSI | 311 | Q8NHY2 | |
| SNNSESPHPSPFSRF | 381 | Q14264 | |
| PSHITTANLPPQISS | 256 | Q96L91 | |
| TQPSPVSTPSSVQFF | 141 | P04920 | |
| FGPSLTNVTNSHSPP | 1961 | Q96N23 | |
| TPFSTPSHPFSLHLQ | 316 | Q9N2J8 | |
| SHPPQIVNSNSNSPS | 386 | O00472 | |
| PAPDQSSTIQLHPAT | 411 | Q9UIF9 | |
| PPDITNSSSQPVDNH | 416 | Q12959 | |
| PSHTSQPVAKTTAAP | 1291 | O00468 | |
| PASPAHTTPQTQSTS | 326 | P15336 | |
| DQSNPAQSPFSPHAS | 781 | Q8NFD5 | |
| QPSATSYSASQVHPP | 2726 | Q8TDJ6 | |
| NSLPASPAHQLSSSP | 996 | Q8TEK3 | |
| TEPFHPPEQASSTQQ | 346 | Q9C0C7 | |
| PTHSIAASISQPQTP | 1041 | O75179 | |
| PAIVTSSPQFAAVPH | 506 | P54253 | |
| SSPSPQQSESLSPAH | 111 | Q9BQE9 | |
| VPFSSGQHSTQSFPP | 226 | Q9UHB7 | |
| SQSTPPQHSSSQPEV | 286 | Q8N0U7 | |
| SPSQSVTPRPSFQHS | 156 | A8MTL3 | |
| PSSTPQSTHAEPQEA | 501 | Q7Z5J4 | |
| PDSAVSQAHLTPSPV | 626 | Q01804 | |
| PNVSVPANTSHSRTP | 156 | Q9BQ51 | |
| GHSPPTSSLVQPQSQ | 491 | P52333 | |
| TSPSHVNLSPNTVPE | 271 | Q96SU4 | |
| GEQSNPAQSPFSPHT | 671 | O14497 | |
| NPQSRSVPPSASHVA | 496 | P00450 | |
| QPPAVSVASSHNSSP | 596 | Q92585 | |
| HPTASPTSSEVQQVP | 411 | Q16849 | |
| ISPHRNPTAASESPF | 176 | P10071 | |
| QSRNFHSSPCPPSIT | 1056 | P10071 | |
| PPHSPQGASSFSTTI | 61 | P43356 | |
| AFHPQPVSRDSAQPS | 946 | Q96JA1 | |
| TVPNTTAPFPTNAST | 1916 | Q2M2H8 | |
| THAYNPKSPPTQNSS | 26 | Q9ULD2 | |
| PTAVTHGFNSTNDPP | 21 | Q7Z3F1 | |
| NPNSPPRQHSSSFTE | 451 | Q13480 | |
| SNPPLPSSTSVFHLD | 2026 | Q5HYC2 | |
| LPSTPPVHTEANFSA | 376 | Q6VAB6 | |
| VSPSTEDAPFQHSPL | 526 | O60318 | |
| PSTAVPSHTPGSSQQ | 306 | Q86V42 | |
| PAAPNPAATSATSVH | 301 | Q8IY33 | |
| HESPSQESPNAPTST | 166 | Q9C000 | |
| TSPNSAHAVSLPPAA | 621 | O14511 | |
| SSSFSPRPTHQFSPP | 71 | Q99502 | |
| SYPPHSVSPTDINTS | 276 | Q99081 | |
| PPPTQQHSITDNSLS | 266 | E9PQR5 | |
| NSPAVSPTTNSTAPF | 531 | Q9Y2L9 | |
| TTQATPNNSHTAPPV | 106 | Q9UQV4 | |
| VTAASRTPQQPTHPS | 376 | Q8N3J3 | |
| RPTPHPTGAQTQTTF | 1691 | P98088 | |
| ATTRPTPHPTGAQTQ | 2061 | P98088 | |
| TPRSNASVNVSHPAP | 136 | Q9HCN3 | |
| TSIPSPSSAFTPAHA | 141 | Q96HC4 | |
| SESTSHPELQAPPNT | 791 | Q9Y5G0 | |
| PSASSPFHFQPSAAS | 1456 | Q9UKK3 | |
| SPPLAQAAAISHSSP | 1246 | Q9BZA7 | |
| PDAAASQTQTSPAHP | 756 | Q6ZSS7 | |
| SQTQTSPAHPSVDPC | 761 | Q6ZSS7 | |
| SVTPSQGQTFHPNSP | 71 | Q9P1G2 | |
| STFLSPQCSPQHSPL | 626 | Q8IZQ8 | |
| QTAHSNTIPTTQAPP | 621 | Q7Z6E9 | |
| PPSVSSNVTHQFTSP | 301 | Q7Z442 | |
| PSTVHQSTIPSNPDS | 336 | P23760 | |
| STPASQLFSPHGSNP | 261 | Q86XN7 | |
| QLFSPHGSNPSTPAA | 266 | Q86XN7 | |
| FPGQVSSAVHTPQPS | 316 | Q86XN7 | |
| ANFSVPVVSAPHSPS | 136 | O75144 | |
| QPSLSPASPHSQGFE | 61 | Q9BZF1 | |
| PSTPQEKSPSGSFHF | 106 | O43182 | |
| PHLTNKSPASSPSSF | 421 | Q14686 | |
| ASVPTHSPYAQPSST | 91 | O15350 | |
| TTVTPVSPSFAHNPK | 1156 | Q9Y4H2 | |
| LTPPSTAFQAHLDSP | 531 | Q8IUM7 | |
| NSDSVTVPPSFPSAH | 986 | O14976 | |
| SPNTSGSSPVIHFTP | 351 | A0AVK6 | |
| RASSPFSNNHPSTPK | 41 | Q6PB30 | |
| QQTPRSPGLFSVHPS | 286 | Q14574 | |
| DSSPFPSSIPHAFQI | 316 | Q7RTS9 | |
| ASSQHPSVPASPQGR | 486 | Q4ZHG4 | |
| PSHGQTTATEPTPAQ | 156 | O00512 | |
| QSPLPSTATSEHVVP | 766 | Q8N3K9 | |
| SPSPTVHASSTPAVN | 616 | O75061 | |
| THPNTPTATTANNPL | 351 | Q86UU0 | |
| PPTTSNSETTQPAFA | 921 | Q53TQ3 | |
| QNTATFSPAISPTHP | 21 | Q96EK6 | |
| SSSEAPVHPALAPNS | 486 | P40197 | |
| PESVASSPQFSDPHL | 536 | Q86Z14 | |
| AVLPHQPVEASPSSS | 146 | P57679 | |
| TSAPPQVFSITEHSP | 4781 | Q8NDH2 | |
| STDHQTPPTSPVQGT | 1026 | Q9UBN7 | |
| LSSPNHSPSQSPNQS | 426 | Q9NZ56 | |
| PAPATTTSHNPLANI | 496 | Q5VT52 | |
| FTATHNTSPAAPPTE | 631 | Q5VT52 | |
| SSSQSAHPPLPVRVF | 41 | P59022 | |
| SPHSNRTTPPEAAQN | 406 | Q7Z5L9 | |
| PPPTQQHSITDNSLS | 266 | E9PJ23 | |
| QSSQEEVPSSPIFPH | 1931 | Q01668 | |
| VGPSVSTPNSQHSSP | 76 | Q9H2S9 | |
| SSTFPEELSPPSHQA | 161 | Q14980 | |
| TSAAVDHPPLPQTSS | 166 | P41218 | |
| PESTPKNQASHPTAT | 761 | Q8NEY1 | |
| NFTSPLESNHSFIPP | 211 | Q9Y3Y4 | |
| PSSPPAEHTQAQVSF | 1666 | Q86VV8 | |
| TATHPANSNIPSTTP | 376 | A4D263 | |
| PDDPTFNSPTVHAFT | 4006 | O75445 | |
| PTSSTNPEVTHDPCN | 126 | Q6NW40 | |
| PSSQRQQEPTTSHDP | 626 | Q9NRF2 | |
| APNSSSPSSPSVEHF | 316 | Q6IEE7 | |
| RSHPTTAPTETNIPQ | 586 | Q96KG9 | |
| QVTVAASSPPAVPSH | 116 | P48378 | |
| TPTSNSSHNPPATDV | 326 | Q8N3V7 | |
| PAAPNTTSPELNLSH | 21 | Q99527 | |
| SPPTFHLAPNTFNVG | 371 | Q96SF7 | |
| STQNSLSCSPPHQSP | 501 | Q96QT6 | |
| QLQIPDAHSAPPTTS | 206 | Q96LK8 | |
| PHVASSPAVPQEATS | 911 | Q5T5P2 | |
| PTHNFSLSPSTLLNP | 616 | Q9UIU6 | |
| QQSSSPFRGHPTQSP | 1256 | Q9C0A6 | |
| PTSHTPTGTANDNIP | 466 | Q2M3G4 | |
| NQPSPAVHSSTVIPT | 1616 | Q9HCD6 | |
| APSFTQPLADHTSTP | 381 | Q13203 | |
| APVSDPQAATSAHPS | 326 | Q6PJ21 | |
| SPHQLLSPSSFSPSA | 141 | Q14181 | |
| PTVNHSGTFSPQAPV | 526 | Q16513 | |
| PQPSTSDPSIANHAS | 376 | Q68BL8 | |
| QPSPQVPATTVAHTA | 411 | Q68BL8 | |
| FNHTQFPPSRSSGLP | 316 | P02786 | |
| PAPETTNESVPFAQH | 471 | O15047 | |
| FSSKQTPPPFTHAST | 596 | Q96KW2 | |
| PQPHPSTTAICQTAV | 381 | Q7RTU9 | |
| THTTVSQVQPPPSKA | 251 | Q9NZQ3 | |
| SQAQATVPPAVPTHT | 951 | Q9C0B9 | |
| SAVQTSTSHNPGLPP | 446 | O60481 | |
| PHTPSTHFASQNQPS | 81 | Q14186 | |
| LPHSVCSPNPNTTST | 3441 | Q86UP3 | |
| FQVPPSPSQGTLSAH | 356 | Q70EL4 | |
| NQPDVSHTSRPSPSI | 166 | Q9ULJ3 | |
| LEHTQAQVPPPSSSS | 241 | Q96MN9 | |
| HRTPPATQTQTFRTP | 336 | Q5T7W0 | |
| HAARAQSPTPSLPAS | 896 | Q9UMS6 | |
| PPAQLTHTQFPAASS | 3316 | Q96T58 | |
| HPTPTSGLFQRQPSS | 1121 | Q6ZVD8 | |
| PPVLSTVANPQSCHS | 301 | Q9NR83 | |
| AFTTPDHAPLSPQSS | 261 | Q5PRF9 | |
| ASSSSAAHPPGVQPQ | 211 | Q92734 | |
| PITTPQAHAQHPTAS | 571 | Q8TEJ3 | |
| PPSNSTRLPEASQAH | 701 | Q96HA7 | |
| HPTNPNLLSPASFFS | 256 | P14679 | |
| TPNFNPPQDHASSLS | 11 | Q8NFJ6 | |
| HQNFSPISNPSPAAS | 361 | Q9UGU0 | |
| LSSALPQPSHSTPQA | 366 | O43151 | |
| NTTPTISPHVPEFTA | 1521 | Q14997 | |
| STSVPASGAHQPPQT | 826 | Q9UPN7 | |
| PSFNPGKTPAQSTHS | 471 | Q9H869 | |
| SSAQSTPGHLFPNVP | 836 | Q5SXM2 | |
| PQPHPSTTAICQTAV | 381 | A6NGW2 | |
| SHSTRSPHSTQNPFP | 1161 | Q5JPB2 | |
| PSFSPSQPQNSSLPH | 126 | Q53SZ7 | |
| SQPQNSSLPHSPCQS | 131 | Q53SZ7 | |
| SPSPPVSLSSHFLQQ | 576 | Q9C0B0 | |
| TANPSSQSSPAPQAH | 2526 | P15822 | |
| VPTSPPASENSSAAH | 821 | Q03167 | |
| HSASAPEPPNTQLQS | 156 | Q15776 | |
| SSVPHNPNKPSAARS | 3661 | Q5THJ4 | |
| VAIFSHQSETTAPPP | 166 | Q13887 | |
| IHSQQSTPFPDSPGF | 5016 | Q9UKN1 | |
| IPSANREPSAFPTNH | 961 | O94898 | |
| HKQTPPTTFAPSETF | 1166 | Q9NR99 | |
| STSHQPPTRIQGAPS | 806 | O75113 | |
| DTVTIPSPPTNVHAS | 496 | Q5VTT5 | |
| TIPPPSSSVAISNHV | 196 | Q8NC96 | |
| SSSVAISNHVTPPPI | 201 | Q8NC96 |